SWX:SDZPharmaceuticals
Does Sandoz’s Expanded Rivaroxaban Range Alter the Bull Case for Sandoz Group (SWX:SDZ)?
Sandoz recently launched new generic strengths of rivaroxaban (10 mg, 15 mg, and 20 mg) in Germany, offering a broader range of anticoagulant therapies at a list price advantage following a successful patent revocation.
This development follows a litigation win and positions Sandoz as the supplier with the most comprehensive range of rivaroxaban film-coated tablets on the German statutory health insurance market, improving access and affordability for patients.
We’ll now assess how Sandoz’s...